Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Document first published:
Page updated:
Topic:
Publication type:

Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) imaging is recommended to be available as a routine commissioning imaging option for adults with high-risk primary or recurrent prostate cancer within the criteria set out in this document.

Document

Commissioning policy: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Commissioning policy: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 347 KB
  • 8 pages

Summary

Published 27 February 2025.

Document

Equality and Health Inequalities Impact Assessment (EHIA): Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Equality and Health Inequalities Impact Assessment (EHIA): Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 235 KB
  • 13 pages

Summary

Published 27 February 2025.

Document

Engagement report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Engagement report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 134 KB
  • 5 pages

Summary

Published 27 February 2025.

Document

Clinical panel report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Clinical panel report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 108 KB
  • 2 pages

Summary

Published 27 February 2025.

Document

Clinical Priorities Advisory Group summary report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Clinical Priorities Advisory Group summary report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 254 KB
  • 16 pages

Summary

Published 27 February 2025.

Document

Public health evidence report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Public health evidence report: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 103 KB
  • 4 pages

Summary

Published 27 February 2025.

Document

Evidence review: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Evidence review: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 214 KB
  • 8 pages

Summary

Published 27 February 2025.

Document

Evidence review: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

Evidence review: Prostate-Specific Membrane Antigen (PSMA) radiotracers in Positron Emission Tomography – Computed Tomography (PETCT) Imaging for individuals with high-risk primary or recurrent prostate cancer (adults)

  • PDF
  • 241 KB
  • 8 pages

Summary

Published 27 February 2025.